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Objective: The blood-brain barrier (BBB) protects the brain by preventing the entry of large molecules; this poses a
major obstacle for the delivery of drugs to the brain. A novel technique using focused ultrasound (FUS) energy
combined with microbubble contrast agents has been widely used for non-invasive trans-cranial BBB opening.
Traditionally, FUS research is conducted with magnetic resonance imaging (MRI) guidance, which is expensive and
poses physical limitations due to the magnetic field. A system that could allow researchers to test brain therapies
without MR intervention could facilitate and accelerate translational research.
Methods: In this study, we present a novel FUS system that uses a custom-built FUS generator mounted on a
motorized stereotaxic apparatus with embedded brain atlas to locally open the BBB in rodents. The system was
initially characterized using a tissue-mimicking phantom. Rodent studies were also performed to evaluate whether
non-invasive, localized BBB opening could be achieved using brain atlas-based targeting. Brains were exposed to
pulsed focused ultrasound energy at 1.06 MHz in rats and 3.23 MHz in mice, with the focal pressure estimated to
be 0.5–0.6 MPa through the skull. BBB opening was confirmed in gross tissue sections by the presence of Evans
blue leakage in the exposed region of the brain and by histological assessment.
Results: The targeting accuracy of the stereotaxic system was better than 0.5 mm in the tissue-mimicking phantom.
Reproducible localized BBB opening was verified with Evans blue dye leakage in 32/33 rats and had a targeting
accuracy of ±0.3 mm. The use of higher frequency exposures in mice enabled a similar precision of localized BBB
opening as was observed with the low frequency in the rat model.
Conclusions: With this dedicated small-animal motorized stereotaxic-FUS system, we achieved accurate targeting
of focused ultrasound exposures in the brain for non-invasive opening of the BBB. This system can be used as an
alternative to MR-guided FUS and offers researchers the ability to perform efficient studies (30 min per experiment
including preparation) at a reduced cost in a conventional laboratory environment.
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For most therapeutic agents aimed at treating central
nervous system (CNS) diseases and disorders, the blood-
brain barrier (BBB) is a primary physiological barrier
limiting drug delivery into the brain parenchyma. The
BBB is a separation present along all capillaries in the
CNS that controls the molecular transport and diffusion
across these blood vessels. The barrier is formed by
layers of cells that are coupled by tight junctions [1, 2].
Only small-molecule drugs with high lipid solubility and
a low molecular mass under 400–500 Da can cross the
BBB in pharmacologically significant amounts, hence ex-
cluding most current therapeutic and imaged agents
from being used in the brain [3, 4].
Non-invasive localized opening of the BBB has been
demonstrated using focused ultrasound (FUS) exposures
combined with circulating intravascular microbubble
ultrasound contrast agents. The exact physical mecha-
nisms governing the interactions between the microbub-
bles and endothelial cells are not known, but it is likely
that when stimulated by ultrasound energy, oscillation of
microbubbles produces mechanical effects induced by
radiation force and/or shear stress on the blood vessel
walls, temporarily opening the BBB without tissue dam-
age [5–7]. This combination of FUS and intravascular
microbubbles offers a unique method for remotely actuat-
ing mechanical energy at the site of small vessels through-
out the brain. Meanwhile, this opening occurs at lower
acoustic power levels than was previously used without
intravenous microbubbles, which makes this method
substantially easier to apply through the intact skull [8].
As early as 2001, Hynynen et al. demonstrated that fo-
cused ultrasound combined with gas bubbles can open
the BBB transiently in rabbits [9]. In 2002, Mesiwala
et al. confirmed that high-intensity focused ultrasound
is capable of a selective and non-destructive disruption
of the BBB in rats [10]. Subsequent studies confirmed
the feasibility of non-invasive localized BBB opening in
rodents as models of human disease [11, 12, 1, 13–16].
However, the small size of rodent brains makes FUS
experiments challenging, necessitating the development
of dedicated small-animal exposure systems [17].
In the majority of studies to date, confirmation and
visualization of BBB opening has been achieved using
magnetic resonance imaging (MRI). T1-weighted im-
aging is often used to confirm successful delivery of
gadolinium-based MR contrast agents across the BBB,
and T2-weighted imaging can evaluate the presence of
tissue damage [18, 19]. The major drawbacks of MR-
guided FUS are the need for MRI-compatible systems,
lack of availability, limited throughput of experiments, and
expense. MR-guided focused ultrasound systems are not
usually accessible to neuroscientists or other researchers
outside of the imaging research field. A method forperforming trans-cranial BBB opening without MR guid-
ance would be desirable in order to lower the barrier to
entry in this field and to achieve broader penetration of
FUS technology in neuroscience.
Previous studies have incorporated systems for BBB
opening outside the MRI environment. One method for
targeting specific regions in the brain is the use of
stereotaxy in combination with an anatomical atlas. This
method is widely used in neuroscience to the injection
of agents or implantation of electrodes in specific regions
of the rodent brain. Liu et al.'s group developed a pinhole-
assisted mechanical scanning device using a stereotaxic
apparatus for BBB opening [13], and Konofagou et al.
applied a stereotaxic frame for localized BBB opening in
rodents [20]. Another method for imaging BBB opening
is multi-photon fluorescence microscopy. The two-photon
microscopy allows in vivo visualization of the cerebral vas-
culature and neurons at the subcellular level [21]. Besides,
cerebrovascular dynamics and kinetics of dye leakage after
FUS sonication can also be imaging with multi-photon
microscopy [22]. However, in order to enable targeting of
the ultrasound focus to a specific functional area in the
brain, MR images are still required in these systems.
In this study, we present a compact stereotaxic-FUS
system to perform trans-cranial localized BBB opening
in rodent models using FUS energy and a stereotaxic
system with a built-in rodent brain atlas. The goal of this
system is to provide a tool for neuroscientists to achieve
non-invasive targeted BBB opening in rodents for behav-
ioral and functional research. Using the rodent brain atlas,
researchers can easily target a specific functional area of
the brain. In this paper, we introduce our stereotaxic-FUS
system, followed by initial accuracy characterization in
tissue-mimicking phantoms and rodents. Successful BBB
opening was confirmed through gross imaging, histopath-
ology, and MR imaging. By all forms of measure, repeat-
able non-invasive localized BBB opening by our rodent
stereotaxic-FUS system was verified.
Methods and materials
Focused ultrasound system and stereotaxic apparatus
Ultrasound was transmitted into the brain using a focused
transducer with a 25-mm diameter and a 20-mm radius of
curvature. The fundamental frequency of the transducer
was 1.06 MHz, and the third harmonic frequency was
3.23 MHz, as measured with an impedance analyzer (Via
Bravo, AEA Technology Inc., Carlsbad, CA, USA). The di-
mensions of the ultrasound focus and the pressure output
of the transducer were characterized using an acoustic
hydrophone tank. A needle hydrophone with a 0.2-mm
active area (HGL-0200, Onda Corporation, Sunnyvale,
CA, USA) was scanned in three dimensions to measure
the spatial pressure distribution of the ultrasound beam at
the focus for each transmission frequency.
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compact driving system comprised of an arbitrary wave-
form generator (LMS271D, Vanuix Corp., Haverhill, MA,
USA), an RF amplifier (NP Technologies, Newbury
Park, CA, USA), high-power low-pass filters, and a
dual-frequency matching circuit that enabled efficient
transmission of power to the transducer at each operat-
ing frequency. This self-contained driving system was
controlled from a laptop computer via USB. One of the
main goals was to produce a portable system for
focused ultrasound that could be easily transported for
experiments.
A standard stereotaxic apparatus (51730 M, Stoelting
Co., Wood Dale, IL, USA) was used to achieve targeting of
ultrasound energy within the brain with an attachment
capable of registering the rat brain atlas (Neurostar,
Tubingen, Germany). These systems are normally used
to achieve precise insertion of electrodes or injection of
materials directly into target regions of the brain. The
method of registering the brain atlas to the rodent in-
volves locating the bregma and lambda on the rodent
skull sutures with a metal pointer. Once the x, y, and z
coordinates of these two locations are identified, the
brain atlas (which is referenced to these points) is im-
mediately registered to the animal. Tilting correction
was performed automatically based on the current ani-
mal to take the difference in brain position and size into
consideration.
Tissue-mimicking phantom
In order to test the spatial accuracy of ultrasound delivery
using the stereotaxic-FUS system, a series of exposures
were performed in a custom-made tissue-mimicking
phantom. The phantom was comprised of a hydrogel
with dissolved bovine serum albumin (BSA), similar to
previous recipes [23], which could be used to capture
the location of the ultrasound focus through coagula-
tion of the BSA. Briefly, gellan gum (1% w/v, Gelrite, CP
Kelco, Atlanta, GA, USA) and salt (0.23% w/v) were
added to and dissolved in deionized, degassed water
(90% v/v). Metamucil (0.18% w/v, P&G, Cincinnati, OH,Table 1 Spatial accuracy characterization with the phantom
Axis Desired (mm) Measured (mm) Error (%
Target A-B
x 0.5 0.5 ± 0.01 ±2
y 0.5 0.5 ± 0.01 ±2
z 0.5 0.5 ± 0.01 ±2
Target A-D
x 1.5 1.5 ± 0.01 ±0.6
y 1.5 1.5 ± 0.01 ±0.6
z 1.5 1.4 ± 0.01 −1.3 ~ −0.USA) was added to the mixture to create ultrasound
scattering. BSA (25% v/v, CF-0020, Boval, Cleburne, TX,
USA) was dissolved in the gel to provide ultrasound
absorption. BSA also provides an optical marker of the
ultrasound focus since the protein undergoes coagulation
when heated above 70°C and creates a visible region of
opacity within the otherwise transparent gel. The heating
of the gel was achieved using a continuous delivery
of ultrasound at the high third harmonic frequency
(3.23 MHz). The recipe for the tissue-mimicking phan-
tom is shown in Table 1. The speed of sound and ultra-
sound attenuation coefficient of the phantom material
were characterized using a hydrophone tank and were
measured to be 1,518 ± 2 m/s and 0.3 ± 0.1 dB/cm (at
1 MHz), respectively.
The spatial accuracy of ultrasound delivery was evalu-
ated by exposing targets with different spacing (0.5, 1, 1.5,
and 2 mm) in all three directions (x, y, z). The tissue-
mimicking phantom was placed in the position where the
rodent head would be located, and the ultrasound trans-
ducer was coupled to it using degassed water. After the
exposures, the distance between the regions of coagulation
in the gel were measured and compared with the desired
separation. Tests were completed in two planes (x-y and
x-z). For each plane, one reference target (A) and four
testing targets (B, C, D, E) were selected to apply the
sonication.
As an important next step, ultrasound exposures were
delivered to the tissue-mimicking phantom in a three-
dimensional (3D) pattern based on the rat brain atlas in
order to cover a spatial region equivalent to the right
motor cortex of the brain. The geometric fidelity of this
ultrasound exposure was evaluated in comparison to the
brain atlas.Animal experiment
Animal preparation
Female 200–270-g Sprague Dawley rats (n = 56) and
female 20–25-g Swiss Webster mice (n = 14) were used
in this study. All procedures were approved by UT) Desired (mm) Measured (mm) Error (%)
Target A-C
1 1 ± 0.01 ±1
1 1 ± 0.01 ±1
1 0.9 ± 0.01 −2 ~ 0
Target A-E
2 2 ± 0.01 ±0.5
2 2 ± 0.01 ±0.5
6 2 1.9 ± 0.01 −1 ~ −0.5
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mittee and followed guidelines set forth by the Guide.
Animals were anesthetized with a mixture of 2%–3.5%
isoflurane and 1–2 l/min of 100% oxygen. A 24G I.V.
catheter was placed in the lateral tail vein. A pulse oxim-
eter was attached to the animal's paw to monitor heart
rate and oxygen saturation, and a rectal temperature probe
(attached to a homeothermic control blanket) was used to
record and maintain core body temperature (PhysioSuite,
Kent Scientific Corp., Torrington, CT, USA). Hair over the
cranial surface of the skull was removed using an animal
trimmer and depilatory cream (VEET sensitive formula,
Reckitt Benckiser, Parsippany, NJ, USA). After prepar-
ation, the animal was transferred to the stereotaxic ap-
paratus and stabilized using ear bars and bite bar. A
custom-built nose cone was placed over the animal's
nose to deliver inhalant anesthetic.
In order to perform brain atlas registration, a skin in-
cision over the skull was performed to identify cranial
landmarks bregma and lambda. Ultrasound gel was ap-
plied on the skull, and a custom-built water reservoir
filled with degassed water was lowered over the skull for
ultrasound gel coupling. The ultrasound probe was
mounted on the stereotaxic system followed by target
selection from the brain atlas. The ultrasound probe
was then automatically moved to the targeted area toFigure 1 Overview of the procedure used to perform trans-cranial ult
system. Step 1: A skin incision is made to expose the skull surface, and a m
An ultrasound coupling chamber is placed over the skull with a thin layer
with degassed water. Step 3: The metal pointer is replaced with a focused
rat brain atlas is used to determine the appropriate distance to move the ugenerate a focus at the specific location. This setup pro-
cedure is described in Figure 1.
Evans blue (2%; 3 ml/kg rats, 4 ml/kg mice) was injected
via the tail vein catheter and allowed to circulate for a
minimum of 1–3 min. A bolus injection of microbubbles
(30 μl/kg rats, 60 μl/kg mice, Optison, GE Healthcare,
Milwaukee, WI, USA) was delivered via the tail vein
catheter, with simultaneous start of ultrasound sonication.
When multiple sonications were performed (in the same
animal), 5 min of wait time was applied to allow micro-
bubbles to clear from circulation.
All brain targets were selected in the right hemisphere
(center of caudoputamen) while the left hemisphere
was kept as a control. Twenty-three rats were utilized
to optimize FUS parameters (frequency, microbubble
dosage, focal pressure, etc.) on BBB opening results.
After optimization, 33 rats were utilized to verify the
reliability of the system and to characterize spatial ac-
curacy. Among those rats, 5 were utilized for histology.
Nineteen mice were utilized to optimize ultrasound
frequencies specific to mouse cranial space and parietal
bone thickness (7 for low frequency, 1.06 MHz, and 12 for
high frequency, 3.23 MHz).
Animals were sacrificed and perfused 5–10 min after
sonication with sterile saline and 10% buffered formalin,
followed by immediate harvesting of the brain. Brainrasound exposures using a standard stereotaxic positioning
etal pointer is used to locate the bregma and lambda sutures. Step 2:
of ultrasound gel between the chamber and skull. The chamber is filled
ultrasound transducer whose focus is now aligned with bregma. The
ltrasound focus to a targeted region in the brain.
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allow for 24–48 h of fixation time. Brains were sliced
using a rat or mouse brain matrix (World Precision In-
strument, Sarasota, FL, USA) to confirm localization of
Evans blue leakage following BBB opening. Photographic
record of Evans blue leakage was made, and a subset of
subgross slices was worked up by histology.
Histological preparation
Subgross coronal brain-matrix slices from perfusion-
fixed animals were paraffin processed, embedded, and
sectioned according to standard procedures [24, 25]. Serial
paraffin sections were prepared at the epicenter of FUS-
mediated hemorrhage, seen by dark-field microscopy [26].
Resulting sections were stained by hematoxylin and eosin
(H&E) and terminal deoxynucleotidyltransferase-mediated
UTP end labeling (TUNEL). H&E-stained sections were
analyzed for histopathologic hallmarks of brain injury
(hemorrhage, edema, nuclear condensation, inflammatory
cell infiltrate, rarefaction). Histologic analysis for possible
ultrasound damage to neuronal and glial cell populations
in the FUS target area was performed via TUNEL; nuclei
of apoptotic and necrotic cells were labeled with fluores-
cein according to methods of the first report [27]. Sections
subjected to TUNEL were counterstained with propidium
iodide.
Ultrasound exposures
Single-frequency pulsed exposures (10-ms burst duration)
were transmitted into the brain with a repetition fre-
quency of 1 Hz and a total exposure duration of 120 s.
In rats, the intracranial peak negative pressure at the
focal point under low frequency (1.06 MHz) was ad-
justed to be between 0.5 and 0.6 MPa, based on the
hydrophone calibration of the transducer and published
measurements of the insertion loss through rat parietal
bone [28]. Similar opening is expected with lower pres-
sure. The threshold for the BBB opening was estimated
to be inversely proportional to the square root of fre-
quency [29]. Prior studies have investigated extensively
the effects of different sonication parameters on the
threshold of BBB opening [18]: frequency [30], pulse width
[31, 32], pulse repetition time [31], total sonication dur-
ation [33], microbubble size [34], and contrast agent dose
[35, 36]. The ultrasound exposure parameters selected for
this study have been shown to achieve consistent opening
of the BBB in rodent models [37]. For the mouse expo-
sures, a 3.23-MHz frequency was used instead of
1.06 MHz in order to achieve a relatively localized ab-
lation within the mouse brain. Skull insertion loss
under high frequency is still unknown, so it was as-
sumed to be approximately 50% based on the skull
thickness. The focused ultrasound energy was adjusted
to achieve a focal pressure of 0.5–0.6 MPa accordingly.Characterization of in vivo targeting accuracy
Evans blue dye has been used frequently as an indicator
of BBB opening. Evans blue binds to albumin which can-
not cross the BBB; therefore, neural tissue remains un-
stained after intravenous administration of the dye [38]. In
these experiments, BBB opening was confirmed on gross
tissue sections based on the leakage of Evans blue dye in
the targeted area of the brain.
As a secondary validation, two rats that received
ultrasound exposures to open the BBB in a targeted region
were administered an intravenous injection of gadodiamide
(0.02 mmol/kg, Omniscan, GE Healthcare, Milwaukee,
WI, USA) and were imaged in a 9.4 T animal imaging and
spectroscopy system (Avance, Varian Medical Systems,
Palo Alto, CA, USA). Contrast-enhanced T1-weighted
spin-echo MR images were obtained to visualize BBB
opening through diffusion of the contrast agent into the
brain parenchyma (field of view 128 × 128, TR/TE 151/
10 ms, slice thickness 1 mm, gap 0 mm, echo number 1).
The spatial targeting accuracy of the system was evalu-
ated through localization of the region of Evans blue
staining on gross sections. Two specific targets were
manually selected using the brain atlas, and the spacing
between targets was measured on the gross sections.
Atlas spacing was compared with measured spacing in
three axes: anterior-posterior (AP), medial-lateral (ML),
and superior-inferior (SI). Reference in ML and SI axes
is the midline of the brain and top surface of the brain,
respectively. For characterization of the AP axis, a refer-
ence point was selected as coordinates 0.00, 3.32, and
5.55 mm (AP, ML, and SI) relative to bregma since the
cranial landmarks disappear after removal of the skull.
Five rats were utilized to characterize targeting accuracy
along each axis.
Results
Focused ultrasound transducer characterization
The spatial pressure distribution produced by the fo-
cused ultrasound transducer, driven at the fundamental
and the third harmonic frequency, was characterized in
an acoustic hydrophone tank. The pressure distributions
are shown in Figure 2 as a 3D map of the ultrasound
beam. The scan was completed in planes of 6 × 10 mm2
along (x-z, y-z) and 6 × 6 mm2 transverse (x-y) to the
beam to cover the entire focal area. Two sidelobes along
the x direction were caused by electrode tabs on the
transducer. The ultrasound transducer was excited with a
20-cycle pulse (40 cycles at the third harmonic frequency)
and 100-Hz repetition frequency signal. The pressure at
each location was acquired as an average of 256 pulses.
The full width at half maximum (FWHM) of the beam
was measured to be 1.6 × 2 × 10 ± 0.1 mm (x × y × z) for
the fundamental frequency and 0.4 × 0.6 × 3 ± 0.1 mm
(x × y × z) for the third harmonic frequency. The beam
A B
EDC
Figure 2 The ultrasound beam plots. (A, B) 3D beam plots for the fundamental and the third harmonic frequency, respectively. At the third
harmonic frequency, the focal area is more compact with higher intensity. (C-E) Intensity profiles in three directions (x, y, z) for the two frequencies. The
peak amplitude could reach 0.25 V at the fundamental frequency (red curve) while 0.38 V at the third harmonic frequency (blue curve).
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spectively. At higher frequency, the focal area is about
46 times more compact. The pressure profile along each
axis (x, y, z) is shown in Figure 2. The peak negative
pressure at the focal point ranged from 0.1 to 0.8 MPa
at the fundamental frequency and from 0.05 to 1.2 MPa
at the third harmonic frequency.
Spatial accuracy characterization—phantom
Figure 3 shows a sample pattern of coagulated volumes
generated in the tissue-mimicking phantom. The desired
separation and measured separation for each target are
included in Table 2. In the x and y axes, the precision of
targeting was approximately 0.01 mm for four different
separations. However, in the z axis, the measured spacing
was smaller than the desired spacing by up to 2%. This
was likely due to the difference in ultrasound attenuation
and sound velocities between the phantom and water.Figure 4 shows the results obtained for generating a
3D ultrasound exposure pattern that overlapped with
the rat brain right motor cortex. The dimension of the
motor cortex model was measured to be 8.4 × 2.84 ×
5.17 mm (L ×H ×W), with 123.34-mm3 volume. The
dimension of the phantom coagulation was measured
to be 8 × 3.4 × 4.6 ± 0.1 mm (L ×H ×W), with 125.12
(117.315 ~ 133.245)-mm3 volume. The percentage error of
pattern volume was within ±10% (−4.88% ~ 8.03%).
Animal studies
Validation
Evidence of successful and confined BBB opening follow-
ing FUS was observed by both Evans blue dye leakage and
contrast-enhanced MR images in the targeted brain area.
Figure 5(A.1) shows the whole brain and targeted brain
slice for rat, under low-frequency (1.06 MHz) sonication.
Evans blue dye can be observed on the cortical brain
Figure 3 Isolated regions of coagulated BSA within the phantom caused by focal heating with the 3.23-MHz transducer. The test was
performed in the x‐z direction (left) and the x‐y direction (right) to measure the separation between individual sonications. The precision of
targeting was approximately 0.01 mm, and the accuracy was less than 2%. The greatest error occurred in the z direction which is due to the
difference in speed of sound between the coupling water and phantom and the different amounts of each in the beam path with different
focal depths.
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ing the location of BBB opening. On the other hand, when
low frequency was also applied in mice for comparison,
Evans blue dye leakage was observed through the entire
targeted hemisphere, likely due to the thinner parietal
bone. In order to achieve a similar tight focus, high fre-
quency (3.23 MHz) was applied in the mouse model.
Figure 5(A.2) shows the BBB opening results for mouse.
In both the rat and mouse models, the un-targeted
hemisphere presents as control. Figure 5(B) renders the
T1-weighted MR images acquired as secondary valid-
ation. B.1 refers to a transverse slice while B.2 refers to
a coronal slice. The presence of an increased signal in
the brain due to extravasation of the contrast agent in-
dicates localized BBB opening.
Spatial accuracy characterization—animal
The system's spatial accuracy relative to the brain atlas
was characterized in three axes: anterior/posterior (AP),
medial/lateral (ML), and superior/inferior (SI). Figure 6
shows a stepwise overview of brain registry as the calvar-
ium was removed. Photos were taken before and after re-
moving the calvarium to indicate the location of bregma
and the reference point. Validation results in three axesTable 2 Spatial accuracy characterization with the rat model
Atlas
spacing (mm) Rat A Rat B
Medial/lateral 3.32 3.5 3.1
4.03 4.2 4.4
Superior/inferior 5.55 5.1 5.4
4.37 4 4.5
Anterior/posterior 3 3.2 3.1
6 6.1 5.9are included in Table 2. Atlas spacing was acquired from
the brain atlas during the targeting procedure. Measured
spacing was acquired from the brain slice after dissection,
relative to references. The location of each exposure was
manually selected to be at the centroid of the focal area.
Percentage error was calculated based on average mea-
sured spacing and atlas spacing. Percentage error for tar-
geting is estimated to be around ±5%.
Histology
As further validation of the rat model, detailed histologic
analysis was performed on coronal-matrix slices collected
immediately following FUS and 72 h post-FUS exposure.
Figure 7 shows ultrasound-induced BBB opening by rou-
tine histopathology. H&Es of acute and 72-h brains both
show evidence of perivascular hemorrhage in the target
region. Hemorrhage was limited to the target area in both
lateral-medial and anterior-posterior axes. Mild perivascu-
lar edema and condensation of adjacent neuronal nuclei
was sparsely evident. Low-magnification images illustrate
the contralateral hemisphere without hemorrhage.
In the absence of major histopathology on H&E in
FUS rat brains, TUNEL was performed to look for
apoptotic and/or necrotic vascular endothelium and theMeasured spacing (mm) Percentage
errorRat C Rat D Rat E
3.0 3.1 3.1 ±6.02
4.0 4.1 3.9 ±4.96
5.7 5.7 5.7 ±3.78
4.1 4.5 4.3 ±4.44
2.9 2.9 3.2 ±4.67
5.8 5.8 6.1 ±2.33
CA
B
Figure 4 Results obtained for generating a 3D ultrasound exposure pattern. (A) A 3D rendering of the right motor cortex (red) and the
brain (yellow), segmented from the standard rat brain atlas. (B) Views of the motor cortex from each of the three principal axes. (C) The
corresponding pattern of coagulated BSA in the gel phantom along the same views and spatial scale. The 3D pattern of coagulation in the gel
phantom was equivalent to the shape of the motor cortex, and the volume was within 10%.
Figure 5 Validation with the animal model. Evans blue dye
leakage served as primary validation. A.1/A.2 shows BBB opening on
the rat/mouse separately. A photo of the entire brain is referred at
the corner; bar is 5 mm. T1‐weighted spin‐echo multi‐slice MR
images (TR/TE, 151/10 ms) were acquired with rat as secondary
validation. B.1 and B.2 show images in transverse and coronal
directions, respectively. Yellow rectangle highlighted the brain, and
contrast enhancement (white arrow) indicates localized BBB opening.
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DNA were detected in the brains from either acute or
72-h post-FUS rats (Figure 8). Images of juvenile mouse
thymus TUNEL-positive control are included in the fig-
ure for contrast to the autofluorescence of extravascular
RBCs present in FUS brain sections.Discussion
This study presented a novel system that interfaces a
stereotaxic brain atlas and a FUS energy transducer to
achieve non-invasive localized BBB opening in rodents,
without MR intervention. The spatial accuracy of the sys-
tem was estimated to be ±2% with the tissue-mimicking
phantom and ±5% with the rodent models. Evans blue dye
leakage was used as a subgross indicator of localized BBB
opening, which was subsequently validated by intact ani-
mal MR imaging of gadolinium contrast agent. Applying
low frequency (1.06 MHz) and high frequency (3.23 MHz)
on rats and mice, respectively, a tight three-dimensional
focus of ultrasound was achieved. This portable system
can be used for rodents' BBB opening in a traditional
laboratory environment.
The primary research application we envision for this
system is for the targeting of regions within the rodent
brain to facilitate functional neuroscience studies in
rodents. Since the majority of these investigations are
conducted in conventional laboratory environments in
close proximity to behavioral testing facilities, a port-
able FUS system that does not require MRI targeting
and guidance is desirable. Furthermore, the brain atlas
A B C
Figure 6 Overview of the dissection procedure applied to verify the accuracy of the reference target. The location of the reference target
is (0, 3.32, 5.55), measured based on bregma. Brain suture and landmarks are shown in (A), whole brain with the skull removed is shown in (C),
and (B) serves as an in‐between photo. White dash line performs as an indicator of bregma.
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the brain in rodents.
To our knowledge, this is the first study to explore the
use of high-frequency FUS exposures in mice for BBB
opening. Exposure of the mouse brain at 1.06 MHz re-
sulted in a very large region of BBB opening in the
brain encompassing the entire AP direction within a
hemisphere. This is due to the thinner parietal bone
and smaller brain size in mice. Exposures at 3.23 MHzA B
C D
Figure 7 H&E-stained sections for acute (A, C) and 72‐h recovery (B, D
location in the brain, indicated by an asterisk. Low-magnification images of
hemispheres. A cutting artifact is observed in (A) on the right cortical regio
(inset in A and B) depicts the cellular architecture in the exposed regions o
can be observed in the acute exposure.achieved a localized region of BBB opening similar in
proportion to the brain as was achieved using 1.06 MHz
in rats. However, unlike experiments with the rat model,
the skull insertion loss is still unknown at this high fre-
quency, and the focal pressure inside the mouse brain was
estimated for this study based on prior measurements at a
lower frequency in the rat skull [28]. Experimental meas-
urement of the insertion loss through the mouse skull
bone at 3 MHz is necessary to obtain more accurate) rats. Both rats received the same ultrasound exposures in the same
the entire brain section (A, B) depict the exposed and control
n and is unrelated to the ultrasound exposure. A × 10 magnified region
f the brain. Evidence of perivascular hemorrhage in the target region
BA C
Figure 8 Tissue sections stained with propidium iodide (red) and TUNEL (green) for acute (A) and 72-h recovery (B) rats. The sections were
taken from the same regions of the brain as are shown in Figure 7C,D. The absence of green staining in the acute and recovery rats demonstrates that
no cells with nicked DNA were present in these regions. An image of juvenile mouse thymus TUNEL-positive control (C) is included at the same
magnification for contrast to the slight green autofluorescence of extravascular red blood cells present in the brain sections exposed to ultrasound.
Bing et al. Journal of Therapeutic Ultrasound 2014, 2:13 Page 10 of 11
http://www.jtultrasound.com/content/2/1/13estimates of the intracranial pressure amplitudes during
these exposures.
The system described in this manuscript still suffers
from a few limitations. In order to achieve BBB opening
within a larger region of the brain, rapid mechanical [17]
or electronic [39] steering of the ultrasound focus is
desirable. The stereotaxic system described in this
study is amenable to these technical improvements,
and this addition would enable regional opening of tar-
get structures within the brain. The incorporation of
acoustic feedback has been demonstrated to achieve
more consistent stable cavitation during ultrasound
exposures for BBB opening [40, 41]. Due to the lack of
imaging confirmation of BBB opening with the stereotaxic
system, this type of feedback would be an important im-
provement to the FUS system. Another limitation of this
approach is that an incision is needed to identify bregma
and lambda. Potential strategies to overcome this would
be to use the external ear bars as a reference point or to
use a technique like high-frequency ultrasound imaging to
non-invasively locate the appropriate stereotactic refer-
ence point on the skull. These approaches will be the sub-
ject of future investigations. Nonetheless, while these
improvements would expand the capabilities of the exist-
ing system, the current configuration is still capable of
consistent opening of the BBB in rodents.
Conclusion
A novel system that interfaces a stereotaxic brain atlas
and a FUS transducer for non-invasive targeted BBB
opening in rodents is presented in this study. The spatial
targeting accuracy of the system was estimated to be ±2%
in tissue-mimicking phantoms and ±5% in the rat brain.
Localized opening of the BBB was achieved at 1.06 MHz
in rats and 3.23 MHz in mice. Consistent opening of the
BBB was verified through Evans blue staining in gross
brain sections and histopathology in H&E-stained tissue
sections. TUNEL staining confirmed that there wasminimal to no apoptosis nor necrosis in the exposed re-
gions of the brain.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CB was the main generator of this manuscript. She was responsible for
developing and characterizing the stereotaxic focused ultrasound system.
She also worked as an operator during the animal experiments for this study.
MW was the veterinary technologist and preclinical coordinator in this study.
She led the animal experiments involved in this project. She also contributed
to the writing of the animal study section in this manuscript. CRW, JMS, and
JAR performed and analyzed the histological tissue sections produced in this
study. They also co-wrote the histology section in this manuscript. RC was
the principal investigator of this study. He came up with the scientific
concept and overall design for the study and reviewed the manuscript.
He also supported the scientific work financially from existing grant support.
All authors read and approved the final manuscript.
Acknowledgements
This study was conducted with the financial support from the Cancer
Prevention & Research Initiative of Texas (Grant No. R1308) and a generous
donation from the M.R. & Evelyn Hudson Foundation. The authors would
also like to acknowledge the efforts provided by Forrest Johnson in the
design and fabrication of the ultrasound transducers used in this study,
Trevor Hinshaw for conducting initial feasibility studies and development of
the tissue-mimicking phantom, and Dr. Dawen Zhao and his group for assisting
with the acquisition of MR images.
Author details
1Department of Radiology, University of Texas Southwestern Medical Center,
5323 Harry Hines Blvd, Dallas, TX 75390-9061, USA. 2Department of Internal
Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines
Blvd, Dallas, TX 75390-9061, USA. 3Department of Pathology, University of
Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX
75390-9061, USA. 4Department of Molecular Biology, University of Texas
Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9061,
USA.
Received: 21 May 2014 Accepted: 11 July 2014
Published: 4 August 2014
References
1. McDannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the
blood-brain barrier with focused ultrasound: association with cavitation
activity. Phys Med Biol. 2006; 51(4):793–807. doi:10.1088/0031-9155/51/4/003.
2. Abbott NJ, Chugani DC, Zaharchuk G, Rosen BR, Lo EH. Delivery of imaging
agents into brain. Adv Drug Deliv Rev. 1999; 37(1–3):253–77.
Bing et al. Journal of Therapeutic Ultrasound 2014, 2:13 Page 11 of 11
http://www.jtultrasound.com/content/2/1/133. Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic
purposes: osmotic opening and other means. Neurosurgery. 1998;
42(5):1083–99. discussion 99–100.
4. Pardridge WM. Blood-brain barrier drug targeting: the future of brain
drug development. Mol Interv. 2003; 3(2):90–105. doi:10.1124/mi.3.2.90.
5. Zhong P, Zhou Y, Zhu S. Dynamics of bubble oscillation in constrained
media and mechanisms of vessel rupture in SWL. Ultrasound Med Biol.
2001; 27(1):119–34.
6. Qin S, Ferrara KW. Acoustic response of compliable microvessels
containing ultrasound contrast agents. Phys Med Biol. 2006;
51(20):5065–88. doi:10.1088/0031-9155/51/20/001.
7. Collis J, Manasseh R, Liovic P, Tho P, Ooi A, Petkovic-Duran K, Zhu Y.
Cavitation microstreaming and stress fields created by microbubbles.
Ultrasonics. 2010; 50(2):273–9. doi:10.1016/j.ultras.2009.10.002.
8. McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K. MRI-
guided targeted blood-brain barrier disruption with focused ultrasound:
histological findings in rabbits. Ultrasound Med Biol. 2005; 31(11):1527–37.
doi:10.1016/j.ultrasmedbio.2005.07.010.
9. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR
imaging-guided focal opening of the blood-brain barrier in rabbits.
Radiology. 2001; 220(3):640–6. doi:10.1148/radiol.2202001804.
10. Mesiwala AH, Farrell L, Wenzel HJ, Silbergeld DL, Crum LA, Winn HR,
Mourad PD. High-intensity focused ultrasound selectively disrupts the
blood-brain barrier in vivo. Ultrasound Med Biol. 2002; 28(3):389–400.
11. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. Local and
reversible blood-brain barrier disruption by noninvasive focused
ultrasound at frequencies suitable for trans-skull sonications. NeuroImage.
2005; 24(1):12–20. doi:10.1016/j.neuroimage.2004.06.046.
12. Hynynen K, McDannold N, Vykhodtseva N, Raymond S, Weissleder R, Jolesz
FA, Sheikov N. Focal disruption of the blood-brain barrier due to 260-kHz
ultrasound bursts: a method for molecular imaging and targeted drug
delivery. J Neurosurg. 2006; 105(3):445–54. doi:10.3171/jns.2006.105.3.445.
13. Liu HL, Pan CH, Ting CY, Hsiao MJ. Opening of the blood-brain barrier by
low-frequency (28-kHz) ultrasound: a novel pinhole-assisted mechanical
scanning device. Ultrasound Med Biol. 2010; 36(2):325–35. doi:10.1016/j.
ultrasmedbio.2009.10.004.
14. Liu HL, Chen HW, Kuo ZH, Huang WC. Design and experimental
evaluations of a low-frequency hemispherical ultrasound phased-array
system for transcranial blood-brain barrier disruption. IEEE Trans Biomed
Eng. 2008; 55(10):2407–16. doi:10.1109/TBME.2008.925697.
15. Choi JJ, Pernot M, Small SA, Konofagou EE. Noninvasive, transcranial and
localized opening of the blood-brain barrier using focused ultrasound in mice.
Ultrasound Med Biol. 2007; 33(1):95–104. doi:10.1016/j.ultrasmedbio.2006.07.018.
16. Deffieux T, Konofagou EE. Numerical study of a simple transcranial focused
ultrasound system applied to blood-brain barrier opening. IEEE Trans Ultrason
Ferroelectr Freq Control. 2010; 57(12):2637–53. doi:10.1109/TUFFC.2010.1738.
17. Chopra R, Curiel L, Staruch R, Morrison L, Hynynen K. An MRI-compatible
system for focused ultrasound experiments in small animal models.
Med Phys. 2009; 36(5):1867–74.
18. O'Reilly MA, Waspe AC, Ganguly M, Hynynen K. Focused-ultrasound
disruption of the blood-brain barrier using closely-timed short pulses:
influence of sonication parameters and injection rate. Ultrasound Med
Biol. 2011; 37(4):587–94. doi:10.1016/j.ultrasmedbio.2011.01.008.
19. McDannold N, Vykhodtseva N, Jolesz FA, Hynynen K. MRI investigation of
the threshold for thermally induced blood-brain barrier disruption and
brain tissue damage in the rabbit brain. Magn Reson Med. 2004;
51(5):913–23. doi:10.1002/mrm.20060.
20. Marquet F, Teichert T, Wu SY, Tung YS, Downs M, Wang S, Chen C, Ferrera V,
Konofagou EE. Real-time, transcranial monitoring of safe blood-brain barrier
opening in non-human primates. PLoS ONE. 2014; 9(2):e84310. doi:10.1371/
journal.pone.0084310.
21. Cho EE, Drazic J, Ganguly M, Stefanovic B, Hynynen K. Two-photon
fluorescence microscopy study of cerebrovascular dynamics in
ultrasound-induced blood-brain barrier opening. J Cereb Blood Flow
Metab. 2011; 31(9):1852–62. doi:10.1038/jcbfm.2011.59.
22. Raymond SB, Treat LH, Dewey JD, McDannold NJ, Hynynen K, Bacskai BJ.
Ultrasound enhanced delivery of molecular imaging and therapeutic
agents in Alzheimer's disease mouse models. PLoS ONE. 2008; 3(5):e2175.
doi:10.1371/journal.pone.0002175.
23. King RL, Liu Y, Maruvada S, Herman BA, Wear KA, Harris GR. Development
and characterization of a tissue-mimicking material for high-intensityfocused ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control. 2011;
58(7):1397–405. doi:10.1109/TUFFC.2011.1959.
24. Shehan DC, Hrapchak BB. Theory and Practice of Histotechnology. 2nd ed.
Columbus: Battelle Press; 1980.
25. Woods AE. Laboratory Histopathology: a Complete Reerence. Edinburgh:
Churchill-Livingston Press; 1996.
26. Shelton JM, Grauer G, Richardson JA, Inventors. Combination Low
Magnification Dark-Field Illuminator and Bright-Field Microscopy Substage
Condenser with Descriptions and Modifications to Manufacture This Device
from Commercially Available Fiber-Optic Ringlights UTSD 1494.
27. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell
death in situ via specific labeling of nuclear DNA fragmentation. J Cell
Biol. 1992; 119(3):493–501.
28. O'Reilly MA, Muller A, Hynynen K. Ultrasound insertion loss of rat parietal
bone appears to be proportional to animal mass at submegahertz
frequencies. Ultrasound Med Biol. 2011; 37(11):1930–7. doi:10.1016/j.
ultrasmedbio.2011.08.001.
29. Huang Y, Hynynen K. MR-guided focused ultrasound for brain ablation
and blood-brain barrier disruption. Methods Mol Biol. 2011; 711:579–93.
doi:10.1007/978-1-61737-992-5_30.
30. McDannold N, Vykhodtseva N, Hynynen K. Blood-brain barrier disruption
induced by focused ultrasound and circulating preformed microbubbles
appears to be characterized by the mechanical index. Ultrasound Med
Biol. 2008; 34(5):834–40. doi:10.1016/j.ultrasmedbio.2007.10.016.
31. Mcdannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters
and ultrasound contrast agent dose on focused-ultrasound induced
blood-brain barrier disruption. Ultrasound Med Biol. 2008; 34(6):930–7.
doi:10.1016/j.ultrasmedbio.2007.11.009.
32. Bing KF, Howles GP, Qi Y, Palmeri ML, Nightingale KR. Blood-brain barrier (BBB)
disruption using a diagnostic ultrasound scanner and Definity® in mice.
Ultrasound Med Biol. 2009; 35(8):1298–308. doi:10.1016/j.ultrasmedbio.2009.03.012.
33. Chopra R, Vykhodtseva N, Hynynen K. Influence of exposure time and pressure
amplitude on blood-brain-barrier opening using transcranial ultrasound
exposures. ACS Chem Neurosci. 2010; 1(5):391–8. doi:10.1021/cn9000445.
34. Choi JJ, Feshitan JA, Baseri B, Wang S, Tung YS, Borden MA, Konofagou EE.
Microbubble-size dependence of focused ultrasound-induced blood-brain
barrier opening in mice in vivo. IEEE Trans Biomed Eng. 2010; 57(1):145–54.
doi:10.1109/TBME.2009.2034533.
35. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K.
Targeted delivery of doxorubicin to the rat brain at therapeutic levels
using MRI-guided focused ultrasound. Int J Cancer J Int du cancer. 2007;
121(4):901–7. doi:10.1002/ijc.22732.
36. Yang FY, Fu WM, Chen WS, Yeh WL, Lin WL. Quantitative evaluation of the
use of microbubbles with transcranial focused ultrasound on blood-
brain-barrier disruption. Ultrason Sonochem. 2008; 15(4):636–43.
doi:10.1016/j.ultsonch.2007.08.003.
37. Nhan T, Burgess A, Cho EE, Stefanovic B, Lilge L, Hynynen K. Drug delivery to
the brain by focused ultrasound induced blood-brain barrier disruption:
quantitative evaluation of enhanced permeability of cerebral vasculature
using two-photon microscopy. J Control Release. 2013; 172(1):274–80.
doi:10.1016/j.jconrel.2013.08.029.
38. Hawkins BT, Egleton RD. Fluorescence imaging of blood-brain barrier
disruption. J Neurosci Methods. 2006; 151(2):262–7. doi:10.1016/j.
jneumeth.2005.08.006.
39. Liu HL, Jan CK, Chu PC, Hong JC, Lee PY, Hsu JD, Lin CC, Huang CY, Chen PY,
Wei K.C. Design and experimental evaluation of a 256-channel dual-
frequency ultrasound phased-array system for transcranial blood-brain
barrier opening and brain drug delivery. IEEE Trans Biomed Eng. 2014;
61(4):1350–60. doi:10.1109/TBME.2014.2305723.
40. Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N. Controlled
ultrasound-induced blood-brain barrier disruption using passive acoustic
emissions monitoring. PLoS ONE. 2012; 7(9):e45783. doi:10.1371/journal.
pone.0045783.
41. O'Reilly MA, Hynynen K. Blood-brain barrier: real-time feedback-controlled
focused ultrasound disruption by using an acoustic emissions-based
controller. Radiology. 2012; 263(1):96–106. doi:10.1148/radiol.11111417.
doi:10.1186/2050-5736-2-13
Cite this article as: Bing et al.: Trans-cranial opening of the blood-brain
barrier in targeted regions using a stereotaxic brain atlas and focused
ultrasound energy. Journal of Therapeutic Ultrasound 2014 2:13.
